Merck's Q2 Revenue Beats Expectations on Strong Keytruda and Treatment Sales

  • 29 days ago
Merck reported second-quarter revenue surpassing Wall Street expectations, driven by strong sales of its cancer drug Keytruda and other treatments. Adjusted earnings per share also exceeded expectations. The company raised its full-year sales forecast slightly but lowered its profit guidance due to acquisition charges. Keytruda sales rose 16%, while sales for its HPV vaccine were nearly flat. The newly launched Winrevair and Capvaxive showed promising starts.

Recommended

0:46
I
Up next
Merck Q1 revenue drops by 9% due to steep decline in Covid antiviral sales
Benzinga
0:41
Exxon Mobil Predicts Fossil Fuels Will Dominate Energy Mix Until 2050, Warns Halting Investment Could Lead to Energy Crisis
Benzinga
0:36
Pharma Bro Martin Shkreli Ordered to Surrender Rare Wu-Tang Clan Album Copies Amid Legal Battle
Benzinga
0:39
Target Beats Q2 Earnings Forecast, but Weak Sales Prompt Guidance Downgrade"
Benzinga
0:45
Lowe's Q2 Earnings Surpass Expectations, But Sales Fall Short
Benzinga
0:34
Temu Parent PDD Holdings Plummets Nearly 30% After Disappointing Q2 Results. Analyst Says, 'Panic Was Overblown' and May Present a Promising Investment Opportunity
Benzinga
0:33
Pfizer's Q2 Revenue and Earnings Beat Expectations, as Sales of Pfizer's COVID Antiviral Pill Surpass Estimates
Benzinga
0:32
Nvidia Partner Sustainable Metal Cloud Is Capitalizing on AI Demand with Energy-Efficient Cooling Centers That Reduce Consumption by 50%
Benzinga
1:17
Donald Trump Unveils New NFT Collection Featuring Debate Memorabilia And Exclusive Perks
Benzinga
0:30
Macy's Lowers Yearly Sales Forecast Amid Cautious Consumer Spending and Mixed Q2 Results
Benzinga
0:53
Walgreens Posts Strong Quarterly Results Despite Decline in COVID Tests
Benzinga
0:42
Pfizer's Share Price Falls After Disappointing Revenue Forecast
Benzinga
0:45
Salesforce Beats Earnings and Revenue Expectations
Benzinga
0:52
Moderna's Q1 Earnings Beat Expectations Despite Covid Vaccine Sales Drop
Benzinga
0:32
DoorDash Exceeds Revenue Expectations in Q2 Performance, Sees Surge in Total Orders
Benzinga
0:35
Novo Nordisk Raises Sales Growth Outlook Despite Profit Miss. CEO Predicts 'Attractive Growth' Amidst Competition and Regulation Shifts.
Benzinga
0:45
J&J's Medical Devices and Pharmaceuticals Drive Impressive Q3 Sales Growth
Benzinga
1:15
AbbVie Sees Increased Drug Sales
Benzinga
0:46
Carvana Expects Positive Earnings Earlier than Anticipated as it Focuses on Profits Over Growth
Benzinga
0:36
Peloton Sees First Revenue Growth Since 2021, But Its End-of-Year Forecast Remains Mixed
Benzinga
0:32
Best Buy's Q1 Earnings Disappoint on Revenue Miss Amid Soft Demand for Consumer Electronics
Benzinga
0:36
Home Depot Beats Q1 Earnings Expectations, but Revenue Falls Short as Customers Delay Renovation Projects
Benzinga
0:37
Target Raises Profit Guidance After Q2 Growth, Credits New Merchandise and Loyalty Programs
Benzinga
0:43
Procter & Gamble Beats Q1 Earnings Estimates
Benzinga
0:35
P&G Beats Earnings Expectations, But Revenue Falls Short as Consumers Struggle with Price Hikes
Benzinga